ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE

Por A. N. Britov
Publicado em 2016-05-01

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure

Por A. N. Britov
Publicado em 2005-06-01

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg

Por A. N. Britov
Publicado em 2009-12-01

Aspirin for thromboembolic complication prevention in cardiovascular disease: dose optimization and adverse effect minimization

Por A. N. Britov
Publicado em 2006-12-01

HIGHLY SELECTIVE BETA-ADRENOBLOCKER BISOPROLOL IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND ASSOCIATED CLINICAL CONDITIONS

Por A. N. Britov
Publicado em 2011-08-01

REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT

Por A. N. Britov, M. M. Bystrova
Publicado em 2016-01-01

Biochemical, structural and clinical analysis of statins’ pleiotropic effects

Por A. N. Britov, O. A. Gomazkov
Publicado em 2009-10-01

Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results

Por A. N. Britov, M. P. Chupina
Publicado em 2011-02-01

Place of agonists Imidazol(in)e Receptors in arterial hypertension patients therapy

Por A. N. Britov, O. A. Orlova
Publicado em 2006-02-01

Some hormonal systems in males with arterial hypertension and metabolic syndrome

Por A. N. Britov, A. M. Inarokova, M. A. Umetov
Publicado em 2006-06-01

Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact

Por Kh. Z. Musieva, A. N. Britov, M. A. Umetov
Publicado em 2008-08-01

Possibilities of Detecting Pre-clinical Forms of Atherosclerosis During Periodic Preventive Inspections in Organized Collectives at Workers of Machine Building Enterprises

Por A. N. Britov, N. A. Eliseeva, A. D. Deev, S. A. Shalnova
Publicado em 2022-05-01

EARLY HEART DISORDERS IN HYPERTENSIVE PERSONS AS THE RESULTS OF PREVENTIVE EXAMINATION ON INDUSTRIAL ENTERPRISE

Por A. N. Britov, E. M. Platonova, T. V. Ryzova, N. A. Eliseeva
Publicado em 2014-04-01

Should psychosocial factors be taken into account when developing and implementing population-level preventive programmes?

Por A. N. Britov, N. A. Eliseeva, A. D. Deev, E. V. Miroshnik
Publicado em 2012-02-01

A STUDY OF SOCIAL AND ECONOMICAL FACTORS IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASES WITH A SCREENING OF 4 TOWNS IN THE MOSCOW REGION

Por A. N. Britov, N. A. Eliseeva, A. D. Deev, S. A. Shalnova, T. S. Kolesnikova
Publicado em 2001-10-01

RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT

Por A. N. Britov, S. A. Tjupaeva, N. A. Eliseeva, A. N. Meshkov, A. D. Deev
Publicado em 2017-12-01

SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED

Por T. V. Aparina, A. N. Britov, E. A. Dilakyan, V. A. Metelskaya, O. A. Gomazkov
Publicado em 2001-04-01

CD40 ligand level – vascular inflammation activity and long6term prognosis in coronary heart disease patients

Por O. P. Shevchenko, O. F. Prirodova, A. O. Shevchenko, O. V. Orlova, A. N. Britov
Publicado em 2008-02-01

Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertensio...

Por T. V. Aparina, A. N. Britov, O. A. Gomazkov, O. N. Yakimenko, T. V. Ektova, E. A. Dilakyan
Publicado em 2005-06-01

THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION

Por M. I. Smirnova, E. M. Platonova, A. N. Britov, V. M. Gorbunov, A. D. Deev, Y. N. Koshelyaevskaya
Publicado em 2015-09-01